GOP FTC Renews Calls For Orange Book Patent Delistings
By Bryan Koenig · May 21, 2025, 7:25 PM EDT
The now-Republican controlled Federal Trade Commission again called on Teva, Novartis, Mylan and other drugmakers to remove patents from a key federal database that partially insulates their drugs from generic competition,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login